|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 173.22 EUR | -0.05% |
|
-8.87% | +15.52% |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 07-08 | BofA Securities Adjusts Biogen Price Target to $217 From $203 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOGEN INC. | Biopharmaceuticals | -0.05% | -8.87% | +15.52% | +51.88% | -44.63% | 29.4B |
-
|
-
|
-
|
- Stock Market
- Stocks
- BIIB Stock
- IDP Stock
- Charts Biogen Inc.
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
